Back to News
Market Impact: 0.4

Celestica Reaches Analyst Target Price

Analyst EstimatesAnalyst InsightsCompany FundamentalsInvestor Sentiment & Positioning
Celestica Reaches Analyst Target Price

Celestica Inc (CLS) shares have recently traded above the average analyst 12-month target price of $13.17, reaching $13.18, a development that typically prompts analysts to either downgrade on valuation or raise their targets. While the average target is based on a range of individual analyst views, the company has seen an increase in "Strong Buy" ratings, improving its overall average rating from 2.33 to 2.14. This price action signals to investors the need to reassess CLS's current valuation and future growth prospects.

Analysis

Celestica Inc. (CLS) shares have reached a critical inflection point by trading at $13.18, marginally surpassing the average 12-month analyst price target of $13.17. This average is derived from a dispersed set of 6 analyst opinions, with targets ranging from a low of $12.00 to a high of $15.00, underscored by a standard deviation of $1.169. The stock's appreciation coincides with a positive shift in analyst sentiment over the last three months, during which the number of 'Strong Buy' ratings increased from two to three, and the average rating improved from 2.33 to 2.14 on a five-point scale where 1 is Strong Buy. This dynamic presents a classic valuation crossroads: the stock has either fulfilled its expected run, suggesting a potential downgrade, or improving fundamentals warrant upward revisions to price targets, a move that would be necessary to justify further gains.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

More News